Cytek Biosciences Inc (CTKB) — Financial Flexibility Index
Cytek Biosciences Inc (CTKB) has a Financial Flexibility Index of 0.00x as of December 2025. Free cash flow of $230.00K (operating CF $-771.00K minus capex $1.00 Million) represents 0% of total liabilities ($119.80 Million). Also explore Cytek Biosciences Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytek Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Cytek Biosciences Inc across 7 annual periods. Check asset allocation strategy of Cytek Biosciences Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Cytek Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Cytek Biosciences Inc. For the full company profile including market capitalisation, see how much is Cytek Biosciences Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-602.00K | $-4.69 Million | $119.80 Million | ▼ -101.8% |
| 2024 | 0.28x | $28.90 Million | $25.38 Million | $103.76 Million | ▲ +179.4% |
| 2023 | 0.10x | $10.11 Million | $5.28 Million | $101.39 Million | ▲ +496.3% |
| 2022 | -0.03x | $-2.36 Million | $-12.23 Million | $93.93 Million | ▼ -116.2% |
| 2021 | 0.16x | $8.99 Million | $4.63 Million | $57.92 Million | ▲ +119.4% |
| 2020 | 0.07x | $16.70 Million | $15.16 Million | $236.01 Million | ▲ +162.1% |
| 2019 | -0.11x | $-12.77 Million | $-13.75 Million | $112.06 Million | — |